Help - Search - Members - Calendar
Full Version: Crohns-Disease
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Crohns-Disease
Pages: 1, 2, 3, 4, 5, 6, 7
  1. Crohns: Igg antibodies against common gut bacteria are more diagnostic for crohn's disease than igg against mannan or flagellin (0 replies)
  2. Crohns: Prochymal for crohn's disease (0 replies)
  3. Crohns: Association of mtrr 66a>g polymorphism with superoxide dismutase and disease activity in patients with crohn's disease (0 replies)
  4. Crohns: Infliximab therapy improves the bone metabolism in fistulizing crohn's disease (0 replies)
  5. Crohns: Ocera therapeutics, inc. completes enrollment in fhast1, a pivotal phase 3 clinical trial in fistulizing crohn's disease (0 replies)
  6. Crohns: Capsule endoscopy 'better than colonoscopy in detecting crohn's recurrence' (0 replies)
  7. Crohns: New cancer drugs could help in autoimmune disease (0 replies)
  8. Crohns: Gentle exercise benefits crohn's disease patients (0 replies)
  9. Crohns: Review article: the evidence base for interventions used to maintain remission in crohn's disease (0 replies)
  10. Crohns: Sonographic assessment of splanchnic arteries and the bowel wall. (0 replies)
  11. Crohns: Luminal antigens access late endosomes of intestinal epithelial cells enriched in mhc i and mhc ii molecules: in vivo study in crohn's ileitis (0 replies)
  12. Crohns: Indian bug is the ancestor of crohn's disease pathogen (0 replies)
  13. Crohns: Indian bug is the ancestor of crohn's disease pathogen (0 replies)
  14. Crohns: Understanding the role of the ancestor of crohn's disease pathogen (0 replies)
  15. Crohns: Information-theoretic metrics for visualizing gene-environment interactions (0 replies)
  16. Crohns: Crohn's disease initially diagnosed after age 60 years (0 replies)
  17. Crohns: Misleading pustular plaques of the lower limbs during crohn's disease: two case reports (0 replies)
  18. Crohns: [brief communications] successful surgical management of acute type a aortic dissection associated with crohn disease (0 replies)
  19. Crohns: Influence of a nucleotide oligomerization domain 1 (nod1) polymorphism and nod2 mutant alleles on crohn's disease phenotype. (0 replies)
  20. Crohns: Tnfalpha blockade in human diseases: an overview of efficacy and safety. (0 replies)
  21. Crohns: Active crohn's in pregnancy ups preterm birth risk (0 replies)
  22. Crohns: Crohn's disease activity in pregnancy linked to risk of preterm birth (0 replies)
  23. Crohns: Are probiotic tablets recommended to be used in crohn's disease? (0 replies)
  24. Crohns: Capsule endoscopy diagnoses more crohn's disease recurrence after surgery than colonoscopy (0 replies)
  25. Crohns: Presence and characterization of mycobacterium avium subspecies paratuberculosis from clinical and suspected cases of crohn's disease and in the healthy human population in india. (0 replies)
  26. Crohns: Systematic review: endoscopic dilation in crohn's disease (0 replies)
  27. Crohns: Imbalanced diet linked with crohn's disease in children (0 replies)
  28. Crohns: Capsule endoscopy detects crohn's recurrence after surgery (0 replies)
  29. Crohns: Correlation of ct enteroclysis with surgical pathology in crohn's disease (0 replies)
  30. Crohns: The place of interventional radiology in crohn disease in children (0 replies)
  31. Crohns: Ultrasonography of crohn disease in children (0 replies)
  32. Crohns: Inflammatory bowel diseases: the paediatric gastroenterologist's perspective (0 replies)
  33. Crohns: Ct and mri of paediatric crohn disease (0 replies)
  34. Crohns: A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating crohn's disease (0 replies)
  35. Crohns: Polymeric formula doesn't improve adherence in crohn's disease (0 replies)
  36. Crohns: Patients with inflammatory bowel disease more likely to die from clostridium difficile infection (0 replies)
  37. Crohns: The prevalence and geographic distribution of crohn's disease and ulcerative colitis in the united states. (0 replies)
  38. Crohns: Capsule endoscopy diagnoses more crohn's disease (0 replies)
  39. Crohns: Pneumoencephalomeningitis complicating crohn's disease: a case report (0 replies)
  40. Crohns: Corrections: maintenance therapy with certolizumab pegol for crohn's disease (0 replies)
  41. Crohns: Capsule endoscopy diagnoses more crohn's disease recurrence after surgery than colonoscopy (0 replies)
  42. Crohns: Drug therapy for inflammatory bowel disease in pregnancy and the puerperium. (0 replies)
  43. Crohns: Surgical treatment of inflammatory bowel diseases and pregnancy. (0 replies)
  44. Crohns: Early surgery benefits crohn's disease patients (0 replies)
  45. Crohns: Il23r r381q and atg16l1 t300a are strongly associated with crohn's disease in a study of new zealand caucasians with inflammatory bowel disease (0 replies)
  46. Crohns: Wheezes, blisters, bumps and runs: multisystem manifestations of a crohn's disease flare-up. (0 replies)
  47. Crohns: Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. (0 replies)
  48. Crohns: Characterization of foxp3(+)cd4(+) regulatory t cells in crohn's disease. (0 replies)
  49. Crohns: Fda advisers endorse natalizumab (tysabri) for crohn's disease (0 replies)
  50. Crohns: Fda advisers endorse natalizumab (tysabri) for crohn's disease (0 replies)
  51. Crohns: Luminal antigens access late endosomes of intestinal epithelial cells enriched in mhc i and mhc ii molecules - in vivo study in crohn's ileitis. (0 replies)
  52. Crohns: Analysts downplay fda committee's green light for biogen drug (0 replies)
  53. Crohns: Analysts downplay fda committee's green light for biogen drug (0 replies)
  54. Crohns: Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum. (0 replies)
  55. Crohns: Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study (0 replies)
  56. Crohns: Joint fda advisory committee recommends approval of tysabri(r) for the treatment of moderate to severe crohn's disease (0 replies)
  57. Crohns: Fda panel recommends us approval of tysabri (natalizumab) for crohn’s disease (0 replies)
  58. Crohns: Mesalazine staves off crohn's disease recurrence. (0 replies)
  59. Crohns: Fda to review tysabri (natalizumab) for crohn's disease (0 replies)
  60. Crohns: Certolizumab pegol effective maintenance therapy for crohn's disease. (0 replies)
  61. Crohns: Invasive escherichia coli are a feature of crohn's disease (0 replies)
  62. Crohns: A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in iceland (0 replies)
  63. Crohns: Certolizumab pegol effective maintenance therapy for crohn's disease (0 replies)
  64. Crohns: Mesalazine staves off crohn's disease recurrence (0 replies)
  65. Crohns: Medical management of mild to moderate crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission (0 replies)
  66. Crohns: Biologics valuable treatment option for patients with inflammatory bowel disease (0 replies)
  67. Crohns: Biogen idec hits setback on drug (0 replies)
  68. Crohns: Biogen idec hits setback on drug (0 replies)
  69. Crohns: Crohn's disease drug not sole possible cause for blood clots, 7th circuit says (0 replies)
  70. Crohns: Options for patients with inflammatory bowel disease (0 replies)
  71. Crohns: Elan and biogen idec preparing to appeal ruling on european application for natalizumab for the treatment of crohn's disease (0 replies)
  72. Crohns: Bayesian association of haplotypes and non-genetic factors to regulatory and phenotypic variation in human populations (0 replies)
  73. Crohns: What would be effect of pregnancy on crohn's disease? (0 replies)
  74. Crohns: Crohn's disease complications (0 replies)
  75. Crohns: Indications for laparoscopic surgery for crohn's disease using the vienna classification (0 replies)
  76. Crohns: Differences in the management of crohn's disease among experts and community providers based on a national survey of sample case vignettes (0 replies)
  77. Crohns: Certolizumab pego found to be effective new therapy for patients with crohn's disease (0 replies)
  78. Crohns: New drug shows promise in treating crohn's disease (0 replies)
  79. Crohns: A prospective open-label trial of remicade(r) in patients with severe exacerbation of crohn's disease requiring hospitalization: a comparison with outcomes previously observed in patients receiving intravenous hydrocortisone. (0 replies)
  80. Crohns: Eu agency denies approval of biogen crohn's treatment (0 replies)
  81. Crohns: Crohn's disease drug not sole possible cause for blood clots, 7th circuit says (0 replies)
  82. Crohns: Heterozygosity for il23r p.arg381gln confers a protective effect against crohn's disease but also against ulcerative colitis (0 replies)
  83. Crohns: Pivotal cimziaâ„¢ data in crohn's disease published in new england journal of medicine (0 replies)
  84. Crohns: New hope for crohn's disease (0 replies)
  85. Crohns: Aventir biotech launches new 510(k) cleared fecal occult blood screen test (0 replies)
  86. Crohns: European regulators reject biogen idec drug (0 replies)
  87. Crohns: Elan and biogen idec preparing to appeal ruling on european application for natalizumab for the treatment of crohn's disease (0 replies)
  88. Crohns: Certolizumab pegol effective for patients with crohn's disease (0 replies)
  89. Crohns: Discovery of gene variant that increases risk for crohn's disease (0 replies)
  90. Crohns: Research shows new therapy is effective for patients with crohn's disease (0 replies)
  91. Crohns: Research shows new therapy is effective for patients with crohn's disease (0 replies)
  92. Crohns: Research shows new therapy is effective for patients with crohn's disease (0 replies)
  93. Crohns: Gene identified for crohn's disease in children (0 replies)
  94. Crohns: New crohn's disease drug shows promise (0 replies)
  95. Crohns: New therapy is effective for patients with crohn's disease, according to studies (0 replies)
  96. Crohns: Ucb presents long-term cimzia(tm) data in crohn's disease (0 replies)
  97. Crohns: Ucb presents long-term cimzia(tm) data in crohn's disease (0 replies)
  98. Crohns: Enzo biochem individualized oral immune regulation therapy may be effective approach to treating crohn's disease (0 replies)
  99. Crohns: New analysis of data shows treatment with abbott's humira(r) (adalimumab) significantly reduced disease-related hospitalization for patients with crohn's disease (0 replies)
  100. Crohns: Study: humira cuts crohn's hospital stays (0 replies)
  101. Crohns: Successful treatment of chronic hepatitis c with pegylated interferon, ribavirin, and infliximab in a patient with crohn's disease (0 replies)
  102. Crohns: Ucb presents long-term cimzia(tm) data in crohn's disease (0 replies)
  103. Crohns: Low-dose naltrexone is effective in patients with active crohn's disease (0 replies)
  104. Crohns: Ucb: ucb presents long-term cimzia(tm) data in crohn's disease (0 replies)
  105. Crohns: [colon] a meta-analysis on the influence of inflammatory bowel disease on pregnancy (0 replies)
  106. Crohns: [letters] magnifying videoendoscopic findings of peyer's patches in the terminal ileum of crohn's disease (0 replies)
  107. Crohns: Low-dose naltrexone is effective in patients with active crohn's disease,. (0 replies)
  108. Crohns: Risk factors for perianal crohn's disease: the role of genotype, phenotype, and ethnicity (0 replies)
  109. Crohns: Crohn's disease: systematic review of assessment of disease severity and its relevance to surgery (0 replies)
  110. Crohns: Crohn's disease and inflammatory bowel disease: 54 tips (0 replies)
  111. Crohns: Meta-analysis: mortality in crohn's disease (0 replies)
  112. Crohns: Inflammatory bowel disease: clinical aspects and established and evolving therapies. (0 replies)
  113. Crohns: Inflammatory bowel disease: cause and immunobiology. (0 replies)
  114. Crohns: [mechanisms of signal transduction] the nod2-rick complex signals from the plasma membrane (0 replies)
  115. Crohns: Lancet review: inflammatory bowel disease (0 replies)
  116. Crohns: Wisconsin physicians service (wps) expands policy to cover pillcam(r) sb as primary diagnostic tool, usa (0 replies)
  117. Crohns: Cases from the bigelow (0 replies)
  118. Crohns: Mip-3{alpha} neutralizing monoclonal antibody protects against tnbs-induced colonic injury and inflammation in mice (0 replies)
  119. Crohns: Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease (0 replies)
  120. Crohns: Smc issues advice on the use of infliximab (remicade) for psoriasis, crohn’s disease, and ulcerative colitis (0 replies)
  121. Crohns: New therapy for patients with crohn's disease identified by researchers (0 replies)
  122. Crohns: New therapy for patients with crohn's disease identified by researchers (0 replies)
  123. Crohns: Smoking influences crohn's disease (0 replies)
  124. Crohns: Adherence to thiopurine treatment in outpatients with crohn's disease (0 replies)
  125. Crohns: Adalimumab may induce remission of crohn's disease (0 replies)
  126. Crohns: New therapy for patients with crohn's disease identified (0 replies)
  127. Crohns: Cd44v7 ligation downregulates the inflammatory immune response in crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria (0 replies)
  128. Crohns: Vertebral fractures and role of low bone mineral density in crohn's disease. (0 replies)
  129. Crohns: Study ids crohn's disease therapy (0 replies)
  130. Crohns: Smoking influences crohn's disease - effect seen on location, severity of the disease in the gastrointestinal tract (0 replies)
  131. Crohns: Smoking influences crohn's disease - effect seen on location, severity of the disease in the gastrointestinal tract (0 replies)
  132. Crohns: Adalimumab in patients with crohn's disease - safety and efficacy in an open-label single centre study (0 replies)
  133. Crohns: Novel crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of ptger4 (0 replies)
  134. Crohns: The 14-bp deletion polymorphism in the hla-g gene displays significant differences between ulcerative colitis and crohn's disease and is associated with ileocecal resection in crohn's disease (0 replies)
  135. Crohns: Serotonin synthesis and uptake in symptomatic patients with crohn's disease in remission. (0 replies)
  136. Crohns: Smoking influences crohn's disease (0 replies)
  137. Crohns: Gain study: adalimumab induction therapy better than placebo for crohns disease patients previously treated with infliximab (0 replies)
  138. Crohns: Crohn's disease at the small bowel imaging by the ultrasound-enteroclysis. (0 replies)
  139. Crohns: Predicting a change in diagnosis from ulcerative colitis to crohn's disease: a nested, case-control study. (0 replies)
  140. Crohns: Study: bowel, nerve diseases linked (0 replies)
  141. Crohns: Abbott's humira® (adalimumab) receives positive opinion from european medicines agency for the treatment of crohn′s disease (0 replies)
  142. Crohns: Cimzia's setback paves way for other tnf inhibitors in crohn's disease (0 replies)
  143. Crohns: Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor [alpha] agents (0 replies)
  144. Crohns: Treatment of crohn disease with anti-tumor necrosis factor agent. (0 replies)
  145. Crohns: Adalimumab induction therapy for crohn disease previously treated with infliximab. a randomized trial. (0 replies)
  146. Crohns: Chmp recommends approval of humira (adalimumab) for the treatment of crohns disease (0 replies)
  147. Crohns: Martius flap: an adjunct for repair of complex, low rectovaginal fistula. (0 replies)
  148. Crohns: Il-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of il-22 in crohn's disease. (0 replies)
  149. Crohns: Diagnostic value of cte in patients with crohn's disease. (0 replies)
  150. Crohns: Mycobacteria and crohn's disease: the endless story. (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.